Pharma News

RioDerm-003 by Rion for Radiodermatitis: Likelihood of Approval

Photo of MEEFRO MEEFRO Send an email February 20, 2024
0 0 Less than a minute

RioDerm-003 is under clinical development by Rion and currently in Phase I for Radiodermatitis.

Source link
#RioDerm003 #Rion #Radiodermatitis #Likelihood #Approval

Photo of MEEFRO MEEFRO Send an email February 20, 2024
0 0 Less than a minute
Photo of MEEFRO

MEEFRO

Related Articles

What is the current valuation of AstraZeneca’s Sabestomig

April 16, 2024

What is the current valuation of AbbVie’s ABBV-400

April 16, 2024

What is the current valuation of Merck’s MK-1084

April 16, 2024

What is the current valuation of AstraZeneca’s AZD-9574

April 16, 2024

Leave a Reply

Your email address will not be published. Required fields are marked *